This ALM covers information and updates relating to the field of Diabetes. New findings and information from new clinical trials and new advances in the field of prevention are essential knowledge for a GP to help manage patients in order to obtain better health outcomes and also assist in delaying progression of related co morbidities and related disease. This ALM also covers developments to the guidelines for management of T2DM and the latest clinical trial results and reviews.
This ALM constitutes 6hours of education – 4 of which are interactive either with case presentations, role plays, discussions or practical skills. Each activity makes provision for a Q&A session which the facilitator helps coordinate. Delegates must include 4 of the interactive workshop activities, that is two thirds of the ALM, to qualify for this ALM.
LEARNING OBJECTIVES
- To develop a clear understanding and skills about which anti-diabetic agent should be used at the various stages of progression of a patient’s type 2 diabetes.
- To implement appropriate management guidelines to reduce renal disease risk in diabetic patients.
- To understand the role of diet and obesity in the management of diabetes.
- To understand the risks and benefits of mono, dual and triple therapies and the role of insulin in the diabetic patient with/without co-morbid conditions especially in relation to renal/CVD disease.
- Patient Safety - Implement a patient register and templates for care plans and a system to recall patient to the practice.
Please see the list of sessions on offer in the Diabetes ALM: